Phase Ii trial of 4'-epi-doxorubicin in advanced carcinoma of head and neck origin

Magee, M.J.; Howard, J.; Bosl, G.J.; Wittes, R.E.

Cancer Treatment Reports 69(1): 125-126

1985


ISSN/ISBN: 0361-5960
PMID: 3855384
Document Number: 247751
Thirty-one patients with advanced head and neck cancer were treated with 4'-epidoxorubicin. Three of 25 evaluable patients with squamous cell carcinoma and two of three with minor salivary gland carcinoma had partial remissions. Four patients received cumulative doses of 680-1270 mg/m2; none developed clinical heart failure.

Document emailed within 1 workday
Secure & encrypted payments